Bunium persicum Seeds Extract in Combination with Vincristine Mediates Apoptosis in MCF-7 Cells through Regulation of Involved Genes and Proteins Expression


Cite item

Full Text

Abstract

Background::Bunium persicum seeds, a member of the Apiaceae family, have historically been consumed as part of the Iranian diet.

Objective::While many of this herb's biological properties have been fully investigated, there is currently no reliable information about its anticancer/cytotoxic properties.

Methods::Herein, we first determined the major bioactive compounds of B. persicum seed extract (BPSE) via GC-Mass analysis. We evaluated the cytotoxicity of the extract alone as well as in combination with vincristine (VCR), a commonly used chemotherapy drug, using MTT assays on two breast cancer cell lines, MCF-7 and MDA-MB-231, as well as a normal breast cancer cell line, MCF-10A. Moreover, these compounds were evaluated in vitro for their anticancer activity using ROS assays, Real-Time PCR, Western blots, flow cytometry, and cell cycle assays.

Results::As a result of our investigation, it was determined that the extract significantly reduced the viability of cancerous cells while remaining harmless to normal cells. The combination of BPSE and VCR also resulted in synergistic effects. BPSE and/or BPSE-VCR treatment increased the intracellular ROS of MCF-7 cells by over twofold. Moreover, the IC30 of BPSE (100 µg/ml) significantly increased the BAX/BCL-2 and P53 gene expression while reducing the expression of the MYC gene. Moreover, treated cells were arrested in the G2 phase of the cell cycle. The BPSE-VCR combination synergistically reduced the NF-κB and increased the Caspase-7 proteins’ expression. The percent of apoptosis in the cells treated with the extract, VCR, and their combination was 27, 11, and 50, respectively.

Conclusions::The present study demonstrated the anticancer activity of the BPSE and its potential for application in combination therapy with VCR.

About the authors

Mohammad Rasoul Samandari-Bahraseman

Department of Plant Production and Genetic Engineering, Faculty of Agriculture,, Lorestan University

Email: info@benthamscience.net

Ahmad Ismaili

Department of Plant Production and Genetic Engineering, Faculty of Agriculture,, Lorestan University

Email: info@benthamscience.net

Saeed Esmaeili-Mahani

Department of Biology, Faculty of Sciences, Shahid Bahonar University of Kerman

Author for correspondence.
Email: info@benthamscience.net

Esmaeil Ebrahimie

La Trobe Genomics Research Platform, School of Life Sciences, College of Science, Health and Engineering, La Trobe University

Author for correspondence.
Email: info@benthamscience.net

Evelin Loit

Chair of Crop Science and Plant Biology, Institute of Agricultural and Environmental Sciences, Estonian University of Life Sciences

Email: info@benthamscience.net

References

  1. Amethiya, Y.; Pipariya, P.; Patel, S.; Shah, M. Comparative analysis of breast cancer detection using machine learning and biosensors. Intelligent Medicine, 2022, 2(2), 69-81. doi: 10.1016/j.imed.2021.08.004
  2. Nikolaou, M.; Pavlopoulou, A.; Georgakilas, A.G.; Kyrodimos, E. The challenge of drug resistance in cancer treatment: A current overview. Clin. Exp. Metastasis, 2018, 35(4), 309-318. doi: 10.1007/s10585-018-9903-0 PMID: 29799080
  3. Łukasiewicz, S.; Czeczelewski, M.; Forma, A.; Baj, J.; Sitarz, R.; Stanisławek, A. Breast cancer-epidemiology, risk factors, classification, prognostic markers, and current treatment strategies—An updated review. Cancers, 2021, 13(17), 4287. doi: 10.3390/cancers13174287 PMID: 34503097
  4. Staff, N.P.; Grisold, A.; Grisold, W.; Windebank, A.J. Chemotherapy-induced peripheral neuropathy: A current review. Ann. Neurol., 2017, 81(6), 772-781. doi: 10.1002/ana.24951 PMID: 28486769
  5. Gidding, C.; Kellie, S.J.; Kamps, W.A.; de Graaf, S.S.N. Vincristine revisited. Crit. Rev. Oncol. Hematol., 1999, 29(3), 267-287. doi: 10.1016/S1040-8428(98)00023-7 PMID: 10226730
  6. Moore, A.; Pinkerton, R. Vincristine: Can its therapeutic index be enhanced? Pediatr. Blood Cancer, 2009, 53(7), 1180-1187. doi: 10.1002/pbc.22161 PMID: 19588521
  7. Yazdani, M.; Hallaj, A.; Salek, F.; Baharara, J. Potential of the combination of Artemisia absinthium extract and cisplatin in inducing apoptosis cascades through the expression of p53, BAX, caspase 3 ratio, and caspase 9 in lung cancer cells (Calu-6). Eur. J. Integr. Med., 2022, 56, 102193. doi: 10.1016/j.eujim.2022.102193
  8. Samandari Bahraseman, M.R.; Khorsand, B.; Esmaeilzadeh-Salestani, K.; Sarhadi, S.; Hatami, N.; Khaleghdoust, B.; Loit, E. The use of integrated text mining and protein-protein interaction approach to evaluate the effects of combined chemotherapeutic and chemopreventive agents in cancer therapy. PLoS One, 2022, 17(11), e0276458. doi: 10.1371/journal.pone.0276458 PMID: 36367850
  9. Martino, E.; Casamassima, G.; Castiglione, S.; Cellupica, E.; Pantalone, S.; Papagni, F.; Rui, M.; Siciliano, A.M.; Collina, S. Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead. Bioorg. Med. Chem. Lett., 2018, 28(17), 2816-2826. doi: 10.1016/j.bmcl.2018.06.044 PMID: 30122223
  10. D’Arcy, M.S. Cell death: A review of the major forms of apoptosis, necrosis and autophagy. Cell Biol. Int., 2019, 43(6), 582-592. doi: 10.1002/cbin.11137 PMID: 30958602
  11. Dolcet, X.; Llobet, D.; Pallares, J.; Matias-Guiu, X. NF-kB in development and progression of human cancer. Virchows Arch., 2005, 446(5), 475-482. doi: 10.1007/s00428-005-1264-9 PMID: 15856292
  12. Guan, C. Zhou, X.; Li, H.; Ma, X.; Zhuang, J. NF-κB inhibitors gifted by nature: The anticancer promise of polyphenol compounds. Biomed. Pharmacother., 2022, 156, 113951. doi: 10.1016/j.biopha.2022.113951 PMID: 36411636
  13. Das, R.; Mehta, D.K.; Dhanawat, M. Medicinal plants in cancer treatment: Contribution of nuclear factor-kappa B (NF-kB) inhibitors. Mini Rev. Med. Chem., 2022, 22(15), 1938-1962. doi: 10.2174/1389557522666220307170126 PMID: 35260052
  14. Patel, M. Horgan, P.G.; McMillan, D.C.; Edwards, J. NF-κB pathways in the development and progression of colorectal cancer. Transl. Res., 2018, 197, 43-56. doi: 10.1016/j.trsl.2018.02.002 PMID: 29550444
  15. Yang, L.; Zhou, Y.; Li, Y.; Zhou, J.; Wu, Y.; Cui, Y.; Yang, G.; Hong, Y. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells. Cancer Lett., 2015, 357(2), 520-526. doi: 10.1016/j.canlet.2014.12.003 PMID: 25499080
  16. Surh, Y.J.; Han, S.S.; Keum, Y-S.; Seo, H-J.; Lee, S.S. Inhibitory effects of curcumin and capsaicin on phorbol ester-induced activation of eukaryotic transcription factors, NF-κB and AP-1. Biofactors, 2000, 12(1-4), 107-112. doi: 10.1002/biof.5520120117 PMID: 11216470
  17. Manson, M.M.; Gescher, A.; Hudson, E.A.; Plummer, S.M.; Squires, M.S.; Prigent, S.A. Blocking and suppressing mechanisms of chemoprevention by dietary constituents. Toxicol. Lett., 2000, 112-113, 499-505. doi: 10.1016/S0378-4274(99)00211-8 PMID: 10720772
  18. Galante, J.M.; Mortenson, M.M.; Schlieman, M.G.; Virudachalam, S.; Bold, R.J. Targeting NF-kB/BCL-2 pathway increases apoptotic susceptibility to chemotherapy in pancreatic cancer. J. Surg. Res., 2004, 121(2), 306-307. doi: 10.1016/j.jss.2004.07.130
  19. Godwin, P.; Baird, A.M.; Heavey, S.; Barr, M.P.; O’Byrne, K.J.; Gately, K. Targeting nuclear factor-kappa B to overcome resistance to chemotherapy. Front. Oncol., 2013, 3, 120. doi: 10.3389/fonc.2013.00120 PMID: 23720710
  20. Pavitra, E.; Kancharla, J.; Gupta, V.K.; Prasad, K.; Sung, J.Y.; Kim, J.; Tej, M.B.; Choi, R.; Lee, J.H.; Han, Y.K.; Raju, G.S.R.; Bhaskar, L.V.K.S.; Huh, Y.S. The role of NF-κB in breast cancer initiation, growth, metastasis, and resistance to chemotherapy. Biomed. Pharmacother., 2023, 163, 114822. doi: 10.1016/j.biopha.2023.114822 PMID: 37146418
  21. Montagut, C.; Tusquets, I.; Ferrer, B.; Corominas, J.M.; Bellosillo, B.; Campas, C.; Suarez, M.; Fabregat, X.; Campo, E.; Gascon, P.; Serrano, S.; Fernandez, P.L.; Rovira, A.; Albanell, J. Activation of nuclear factor-κB is linked to resistance to neoadjuvant chemotherapy in breast cancer patients. Endocr. Relat. Cancer, 2006, 13(2), 607-616. doi: 10.1677/erc.1.01171 PMID: 16728586
  22. Levi, M.; Borne, R.; Williamson, J. A review of cancer chemopreventive agents. Curr. Med. Chem., 2001, 8(11), 1349-1362. doi: 10.2174/0929867013372229 PMID: 11562271
  23. Alshabi, A.M.; Alkahtani, S.A.; Shaikh, I.A.; Orabi, M.A.A.; Abdel-Wahab, B.A.; Walbi, I.A.; Habeeb, M.S.; Khateeb, M.M.; Hoskeri, J.H.; Shettar, A.K.; Basheeruddin, A. S.M. Phytochemicals from Corchorus olitorius methanolic extract induce apoptotic cell death via activation of caspase-3, anti-Bcl-2 activity, and DNA degradation in breast and lung cancer cell lines. J. King Saud Univ. Sci., 2022, 34(7), 102238. doi: 10.1016/j.jksus.2022.102238
  24. Kamarya, Y.; Lijie, X.; Jinyao, L. Chemical constituents and antitumor mechanisms of artemisia. Anticancer. Agents Med. Chem., 2022, 22, 1838-1844.
  25. Samandari-Bahraseman, M.R.; Khorsand, B.; Zareei, S.; Amanlou, M.; Rostamabadi, H. Various concentrations of hesperetin induce different types of programmed cell death in human breast cancerous and normal cell lines in a ROS-dependent manner. Chem. Biol. Interact., 2023, 382, 110642. doi: 10.1016/j.cbi.2023.110642 PMID: 37487865
  26. Zhang, H.; Wang, Y.; Wang, S.; Wang, Q.; Wang, T.; Zhu, J.; Liu, B. Cytotoxic sesquiterpenes from Sonchus oleraceus. Anticancer. Agents Med. Chem., 2020, 20, 709-714.
  27. Wei, Y.; Yang, P.; Cao, S.; Zhao, L. The combination of curcumin and 5-fluorouracil in cancer therapy. Arch. Pharm. Res., 2018, 41(1), 1-13. doi: 10.1007/s12272-017-0979-x PMID: 29230689
  28. Singh, C.K.; George, J.; Ahmad, N. Resveratrol-based combinatorial strategies for cancer management. Ann. N. Y. Acad. Sci., 2013, 1290(1), 113-121. doi: 10.1111/nyas.12160 PMID: 23855473
  29. Samandari-bahraseman, M.R.; Sarhadi, S.; Esmaili-mahani, S. Artemether effect and its interaction with vincristine and doxorubicin on human breast carcinoma MCF-7 cells Physiol. Pharmacol., 2016, 20(2), 117-121.
  30. Shakibaei, M.; Mobasheri, A.; Lueders, C.; Busch, F.; Shayan, P.; Goel, A. Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-κB and Src protein kinase signaling pathways. PLoS One, 2013, 8(2), e57218. doi: 10.1371/journal.pone.0057218 PMID: 23451189
  31. Hassanzadazar, H.; Taami, B.; Aminzare, M.; Daneshamooz, S. Bunium persicum (Boiss.) B. Fedtsch: An overview on phytochemistry, Therapeutic uses and its application in the food industry. J. Appl. Pharm. Sci., 2018, 8(10), 150-158. doi: 10.7324/JAPS.2018.81019
  32. Chizzola, R.; Saeidnejad, A.H.; Azizi, M.; Oroojalian, F.; Mardani, H. Bunium persicum: variability in essential oil and antioxidants activity of fruits from different Iranian wild populations. Genet. Resour. Crop Evol., 2014, 61(8), 1621-1631. doi: 10.1007/s10722-014-0158-6
  33. Deeptha, K.; Kamaleeswari, M.; Sengottuvelan, M.; Nalini, N. Dose dependent inhibitory effect of dietary caraway on 1,2-dimethylhydrazine induced colonic aberrant crypt foci and bacterial enzyme activity in rats. Invest. New Drugs, 2006, 24(6), 479-488. doi: 10.1007/s10637-006-6801-0 PMID: 16598436
  34. Bogucka-Kocka, A.; Smolarz, H.D.; Kocki, J. Apoptotic activities of ethanol extracts from some Apiaceae on human leukaemia cell lines. Fitoterapia, 2008, 79(7-8), 487-497. doi: 10.1016/j.fitote.2008.07.002 PMID: 18672039
  35. Sharififar, F.; Yassa, N.; Mozaffarian, V. Bioactivity of major components from the seeds of Bunium persicum (Boiss.). Fedtch. Pak. J. Pharm. Sci., 2010, 23(3), 300-304. PMID: 20566444
  36. Geraghty, R.J.; Capes-Davis, A.; Davis, J.M.; Downward, J.; Freshney, R.I.; Knezevic, I.; Lovell-Badge, R.; Masters, J.R.W.; Meredith, J.; Stacey, G.N.; Thraves, P.; Vias, M. Guidelines for the use of cell lines in biomedical research. Br. J. Cancer, 2014, 111(6), 1021-1046. doi: 10.1038/bjc.2014.166 PMID: 25117809
  37. Kamiloglu, S.; Sari, G.; Ozdal, T.; Capanoglu, E. Guidelines for cell viability assays. Food Front., 2020, 1(3), 332-349. doi: 10.1002/fft2.44
  38. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods, 1983, 65(1-2), 55-63. doi: 10.1016/0022-1759(83)90303-4 PMID: 6606682
  39. Murphy, M.P.; Bayir, H.; Belousov, V.; Chang, C.J.; Davies, K.J.A.; Davies, M.J.; Dick, T.P.; Finkel, T.; Forman, H.J.; Janssen-Heininger, Y.; Gems, D.; Kagan, V.E.; Kalyanaraman, B.; Larsson, N.G.; Milne, G.L.; Nyström, T.; Poulsen, H.E.; Radi, R.; Van Remmen, H.; Schumacker, P.T.; Thornalley, P.J.; Toyokuni, S.; Winterbourn, C.C.; Yin, H.; Halliwell, B. Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivo. Nat. Metab., 2022, 4(6), 651-662. doi: 10.1038/s42255-022-00591-z PMID: 35760871
  40. Deepak, S.; Kottapalli, K.; Rakwal, R.; Oros, G.; Rangappa, K.; Iwahashi, H.; Masuo, Y.; Agrawal, G.; Real-time, P.C.R. revolutionizing detection and expression analysis of genes. Curr. Genomics, 2007, 8(4), 234-251. doi: 10.2174/138920207781386960 PMID: 18645596
  41. Begum, H.; Murugesan, P.; Tangutur, A.D. Western blotting: A powerful staple in scientific and biomedical research. Biotechniques, 2022, 73(1), 58-69. doi: 10.2144/btn-2022-0003 PMID: 35775367
  42. Lakshmanan, I.; Batra, S. Protocol for apoptosis assay by flow cytometry using annexin V staining method. Bio Protoc., 2013, 3(6), e374. doi: 10.21769/BioProtoc.374 PMID: 27430005
  43. Riccardi, C.; Nicoletti, I. Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat. Protoc., 2006, 1(3), 1458-1461. doi: 10.1038/nprot.2006.238 PMID: 17406435
  44. Ebada, M.E. Cuminaldehyde: A potential drug candidate. J. Pharmcol. Clin. Res., 2017, 2(2), 1-4. doi: 10.19080/JPCR.2017.02.555585
  45. Li, Y.; Wen, J.; Du, C.; Hu, S.; Chen, J.; Zhang, S.; Zhang, N.; Gao, F.; Li, S.; Mao, X.; Miyamoto, H.; Ding, K. Thymol inhibits bladder cancer cell proliferation via inducing cell cycle arrest and apoptosis. Biochem. Biophys. Res. Commun., 2017, 491(2), 530-536. doi: 10.1016/j.bbrc.2017.04.009 PMID: 28389245
  46. Yasodha, R.; Ghosh, M.; Sumathi, R.; Gurumurthi, K. Cross-species amplification of eucalyptus SSR markers in Casuarinaceae. Acta Bot. Croat., 2005, 64, 115-120.
  47. Singh, R.K.; Ranjan, A.; Srivastava, A.K.; Singh, M.; Shukla, A.K.; Atri, N.; Mishra, A.; Singh, A.K.; Singh, S.K. Cytotoxic and apoptotic inducing activity of Amoora rohituka leaf extracts in human breast cancer cells. J. Ayurveda Integr. Med., 2020, 11(4), 383-390. doi: 10.1016/j.jaim.2018.12.005 PMID: 30846274
  48. Bahmani, F.; Esmaeili, S.; Bashash, D.; Dehghan-Nayeri, N.; Mashati, P.; Gharehbaghian, A. Centaurea albonitens extract enhances the therapeutic effects of Vincristine in leukemic cells by inducing apoptosis. Biomed. Pharmacother., 2018, 99, 598-607. doi: 10.1016/j.biopha.2018.01.101 PMID: 29710458
  49. Dogani, M.; Askari, N.; Kalantari-Hesari, A.; Hosseini, R. F. The effects of P. atlantica as a libido booster and sexual enhancer on the reproductive system of male rats. J. Tradit. Complement. Med., 2022, 12(4), 345-353. doi: 10.1016/j.jtcme.2021.09.007 PMID: 35747351
  50. Khorrami, S.; Zarrabi, A.; Khaleghi, M.; Danaei, M.; Mozafari, M.R. Selective cytotoxicity of green synthesized silver nanoparticles against the MCF-7 tumor cell line and their enhanced antioxidant and antimicrobial properties. Int. J. Nanomedicine, 2018, 13, 8013-8024. doi: 10.2147/IJN.S189295 PMID: 30568442
  51. Fraga, C.G.; Galleano, M.; Verstraeten, S.V.; Oteiza, P.I. Basic biochemical mechanisms behind the health benefits of polyphenols. Mol. Aspects Med., 2010, 31(6), 435-445. doi: 10.1016/j.mam.2010.09.006 PMID: 20854840
  52. Yang, Y.; Zhang, Z.; Li, S.; Ye, X.; Li, X.; He, K. Synergy effects of herb extracts: Pharmacokinetics and pharmacodynamic basis. Fitoterapia, 2014, 92, 133-147. doi: 10.1016/j.fitote.2013.10.010 PMID: 24177191
  53. Marchi, S.; Giorgi, C.; Suski, J.M.; Agnoletto, C.; Bononi, A.; Bonora, M.; De Marchi, E.; Missiroli, S.; Patergnani, S.; Poletti, F.; Rimessi, A.; Duszynski, J.; Wieckowski, M.R.; Pinton, P. Mitochondria-ros crosstalk in the control of cell death and aging. J. Signal Transduct., 2012, 2012, 1-17. doi: 10.1155/2012/329635 PMID: 22175013
  54. Danwilai, K.; Konmun, J.; Sripanidkulchai, B.; Subongkot, S. Antioxidant activity of ginger extract as a daily supplement in cancer patients receiving adjuvant chemotherapy: A pilot study. Cancer Manag. Res., 2017, 9, 11-18. doi: 10.2147/CMAR.S124016 PMID: 28203106
  55. Fattahi, S.; Ardekani, A.M.; Zabihi, E.; Abedian, Z.; Mostafazadeh, A.; Pourbagher, R.; Akhavan-Niaki, H. Antioxidant and apoptotic effects of an aqueous extract of Urtica dioica on the MCF-7 human breast cancer cell line. Asian Pac. J. Cancer Prev., 2013, 14(9), 5317-5323. doi: 10.7314/APJCP.2013.14.9.5317 PMID: 24175819
  56. Rostamabadi, H.; Samandari, B. M.R.; Esmaeilzadeh-Salestani, K. Froriepia subpinnata Leaf extract-induced apoptosis in the MCF-7 breast cancer cell line by increasing intracellular oxidative stress. Iran. J. Pharm. Res., 2023. In Press doi: 10.5812/ijpr-136643
  57. Ganjouzadeh, F.; Khorrami, S.; Gharbi, S. Controlled cytotoxicity of Ag-GO nanocomposite biosynthesized using black peel pomegranate extract against MCF-7 cell line. J. Drug Deliv. Sci. Technol., 2022, 71, 103340. doi: 10.1016/j.jddst.2022.103340
  58. Doonan, F.; Cotter, T.G. Morphological assessment of apoptosis. Methods, 2008, 44(3), 200-204. doi: 10.1016/j.ymeth.2007.11.006 PMID: 18314050
  59. Chaabane, W. User, S.D.; El-Gazzah, M.; Jaksik, R.; Sajjadi, E.; Rzeszowska-Wolny, J.; Łos, M.J. Autophagy, apoptosis, mitoptosis and necrosis: interdependence between those pathways and effects on cancer. Arch. Immunol. Ther. Exp., 2013, 61(1), 43-58. doi: 10.1007/s00005-012-0205-y PMID: 23229678
  60. Nichani, K.; Li, J.; Suzuki, M.; Houston, J.P. Evaluation of Caspase-3 activity during apoptosis with fluorescence lifetime-based cytometry measurements and phasor analyses. Cytometry A, 2020, 97(12), 1265-1275. doi: 10.1002/cyto.a.24207 PMID: 32790129
  61. Fletcher, J.I.; Meusburger, S.; Hawkins, C.J.; Riglar, D.T.; Lee, E.F.; Fairlie, W.D.; Huang, D.C.S.; Adams, J.M. Apoptosis is triggered when prosurvival Bcl-2 proteins cannot restrain Bax. Proc. Natl. Acad. Sci. USA, 2008, 105(47), 18081-18087. doi: 10.1073/pnas.0808691105 PMID: 18981409
  62. Khaleghi, M.; Khorrami, S.; Jafari-Nasab, T. Pediococcus acidilactici isolated from traditional cheese as a potential probiotic with cytotoxic activity against doxorubicin-resistant MCF-7 cells. 3 Biotech., 13, 1-11.
  63. Uzoigwe, J.; Sauter, E.R. Cancer prevention and treatment using combination therapy with plant- and animal-derived compounds. Expert Rev. Clin. Pharmacol., 2012, 5(6), 701-709. doi: 10.1586/ecp.12.62 PMID: 23234327
  64. Sauter, E.R. Cancer prevention and treatment using combination therapy with natural compounds. Expert Rev. Clin. Pharmacol., 2020, 13(3), 265-285. doi: 10.1080/17512433.2020.1738218 PMID: 32154753
  65. Rengarajan, T.; Nandakumar, N.; Rajendran, P.; Haribabu, L.; Nishigaki, I.; Balasubramanian, M.P. D-pinitol promotes apoptosis in MCF-7 cells via induction of p53 and Bax and inhibition of Bcl-2 and NF-κ. B. Asian Pac. J. Cancer Prev., 2014, 15(4), 1757-1762. doi: 10.7314/APJCP.2014.15.4.1757 PMID: 24641404
  66. Mortezaee, K. Najafi, M.; Farhood, B.; Ahmadi, A.; Shabeeb, D.; Musa, A.E. NF-κB targeting for overcoming tumor resistance and normal tissues toxicity. J. Cell. Physiol., 2019, 234(10), 17187-17204. doi: 10.1002/jcp.28504 PMID: 30912132
  67. Wang, C.Y. Guttridge, D.C.; Mayo, M.W.; Baldwin, A.S., Jr NF-κB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol. Cell. Biol., 1999, 19(9), 5923-5929. doi: 10.1128/MCB.19.9.5923
  68. Dorai, T.; Aggarwal, B.B. Role of chemopreventive agents in cancer therapy. Cancer Lett., 2004, 215(2), 129-140. doi: 10.1016/j.canlet.2004.07.013 PMID: 15488631
  69. Muir, H. Blinded by the light The Growing Complexity of p53. New Sci., 2001, 171, 18.
  70. Elbadawy, M.; Usui, T.; Yamawaki, H.; Sasaki, K. Emerging roles of C-myc in cancer stem cell-related signaling and resistance to cancer chemotherapy: A potential therapeutic target against colorectal cancer. Int. J. Mol. Sci., 2019, 20(9), 2340. doi: 10.3390/ijms20092340 PMID: 31083525
  71. Hermeking, H. The MYC oncogene as a cancer drug target. Curr. Cancer Drug Targets, 2003, 3(3), 163-175. doi: 10.2174/1568009033481949 PMID: 12769686
  72. Chen, Z.; Zhang, B.; Gao, F.; Shi, R. Modulation of G2/M cell cycle arrest and apoptosis by luteolin in human colon cancer cells and xenografts. Oncol. Lett., 2017, 15(2), 1559-1565. doi: 10.3892/ol.2017.7475 PMID: 29434850
  73. Tuli, H.S.; Mistry, H.; Kaur, G.; Aggarwal, D.; Garg, V.K.; Mittal, S.; Yerer, M.B.; Sak, K.; Khan, M.A. Gallic acid: A dietary polyphenol that exhibits anti-neoplastic activities by modulating multiple oncogenic targets. Anticancer. Agents Med. Chem., 2022, 22, 499-514.
  74. Ergul, M.; Bakar-Ates, F. Investigation of molecular mechanisms underlying the antiproliferative effects of colchicine against PC3 prostate cancer cells. Toxicol. In Vitro, 2021, 73, 105138. doi: 10.1016/j.tiv.2021.105138 PMID: 33684465
  75. Xia, W.; Spector, S.; Hardy, L.; Zhao, S.; Saluk, A.; Alemane, L.; Spector, N.L. Tumor selective G 2/M cell cycle arrest and apoptosis of epithelial and hematological malignancies by BBL22, a benzazepine. Proc. Natl. Acad. Sci. USA, 2000, 97(13), 7494-7499. doi: 10.1073/pnas.97.13.7494 PMID: 10861014
  76. Hu, A.; Huang, J.J.; Zhang, J.F.; Dai, W.J.; Li, R.L.; Lu, Z.Y.; Duan, J.L.; Li, J.P.; Chen, X.P.; Fan, J.P.; Xu, W.H.; Zheng, H.L. Curcumin induces G2/M cell cycle arrest and apoptosis of head and neck squamous cell carcinoma in vitro and in vivo through ATM/Chk2/p53-dependent pathway. Oncotarget, 2017, 8(31), 50747-50760. doi: 10.18632/oncotarget.17096 PMID: 28881600

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Bentham Science Publishers